Drugs / D20W
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00460499 Comparator | Jul 2004 → Mar 2015 | glucose metabolism disease | American Heart Association | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D20W | “This group will receive D20W+160units IV insulin to keep blood sugar between 120-180mg/dl” NCT00460499 ↗ |